We are live on
!
Find out more
BCM
Bratton Capital Management Portfolio holdings
AUM
$40.7M
1-Year Est. Return
43.1%
This Fund
S&P 500
This Quarter
Est. Return
-2.8%
1 Year Est. Return
+43.1%
3 Year Est. Return
+264.04%
5 Year Est. Return
-20.19%
10 Year Est. Return
–
AUM
$51M
AUM Growth
-$10.5M
(-17%)
Cap. Flow
-$9M
Cap. Flow
% of AUM
-17.65%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aquestive Therapeutics
AQST
|
+$9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SCM
VI
CPCM
CIC
LSA
SIM
CF
ICP
Bratton Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Bratton Capital Management held 1 position worth $51M, down 17% from $61.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bratton Capital Management withdrew a net $9M in Q1 2021, reducing 1 holding. Its largest reduction was Aquestive Therapeutics, cutting an estimated $9M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Bratton Capital Management's biggest Q1 2021 reduction was Aquestive Therapeutics, cutting an estimated $9M.
- Bratton Capital Management's ten largest holdings make up 100% of its $51M portfolio in Q1 2021.
- Bratton Capital Management opened 0 new positions and closed 0 in Q1 2021.
- Bratton Capital Management's portfolio value fell 17% quarter-over-quarter to $51M.
Based on Bratton Capital Management's 13F filing for Q1 2021, filed 14 May 2021.